Kathrin Radig

MDM2 amplification and loss of heterozygosity at Rb and p53 genes: no simultaneous alterations in the oncogenesis of liposarcomas

Hajo Walter, Kathrin Radig, Janusz Ryś et al. · Journal of Cancer Research and Clinical Oncology · 1998 · 66 citations · Full text

Mdm2 Amplification, Oncogenic Agent, Medicine +9

Desmoplastic Small Round Cell Tumor

Ivo Leuschner, Kathrin Radig, D. Harms · SpringerReference · 2012 · 59 citations

Clinicopathologiclmplications of MDM2, p53 and K-ras gene alterations in osteosarcomas: MDM2 amplification and p53 mutations found in progressive tumors

Ryohei Yokoyama, Regine Schneider‐Stock, Kathrin Radig et al. · Pathology - Research and Practice · 1998 · 50 citations

Mdm2 Amplification, P53 Mutations, Malignant Disease +7

Expression of growth factors and their receptors in human osteosarcomas. Immunohistochemical detection of epidermal growth factor, platelet-derived growth factor and their receptors: its correlation with proliferating activities and p53 expression.

Yoshinao Oda, B. Wehrmann, Kathrin Radig et al. · PubMed · 1995 · 46 citations

Epidermal Growth Factor, Bone Morphogenic Protein, Platelet-derived Growth Factor +13

On telomere shortening in soft-tissue tumors

Regine Schneider‐Stock, Cornelia Epplen, Kathrin Radig et al. · Journal of Cancer Research and Clinical Oncology · 1998 · 40 citations · Full text

Tumor Biology, Tumoral Pathology, Pathology +3